The transition from cannabis induced psychosis to primary psychosis: factors that question the validity of the diagnosis “cannabis-induced psychosis”
European Psychiatry April 1, 2025 DOI: 10.1192/j.eurpsy.2025.48
Summary
AI-generated from the abstractA register-based study using Norwegian national patient data from 2010 to 2015 found that people initially diagnosed with substance-induced psychosis face a six-year cumulative risk of later developing schizophrenia of 27.6%. The risk was highest for those whose initial diagnosis was cannabis-induced psychosis, at 36%. These high transition rates raise questions about whether the initial diagnosis was correct or whether the psychosis was an early sign of a primary psychotic disorder masked by cannabis use. The authors argue that the diagnostic label 'cannabis-induced psychosis' overemphasizes substance use and overlooks other factors such as genetic vulnerability.
Study at a glance
| Characteristics | Register-based study Peer reviewed |
|---|---|
| Population | People in Norway diagnosed with substance-induced psychosis or cannabis-induced psychosis between 2010 and 2015 |
| Duration | 6-year follow-up |
| Key finding | The six-year cumulative hazard for transition from cannabis-induced psychosis to schizophrenia was 36%, higher than the 27.6% for any substance-induced psychosis. |
Abstract
Abstract Background: Substance-induced psychosis is an acute psychotic condition occurring after substance use, where the psychotic symptoms are alleviated with abstinence. Some of those diagnosed with substance-induced psychosis later develop schizophrenia, and this transition occurs most often for psychosis induced by cannabis. This talk will present results from a register-based study investigating transition rates. The results will be discussed together with other factors that together question the validity of the diagnostic entity of “cannabis-induced psychosis” Method: In our study, we used data from National Patient Register in Norway from 2010 to 2015 to estimate the cumulative hazard for transition from any substance-induced psychosis (F1x.5) and cannabis-induced psychosis (F12.5) to schizophrenia spectrum disorder (F20, F22 and F23). Results: The six-year cumulative hazard for transition from substance-induced psychosis to schizophrenia was 27.6% (25.6-29.7) for any SIP, and highest for those with cannabis-induced psychosis, 36% (95% CI 31.4-41.0). Conclusion: Cannabis-induced psychosis constitutes a significant risk for later schizophrenia. This raises a question of whether the initial diagnosis of CIP was correct, or whether these may have been cases of a development of primary psychosis concealed by cannabis use. Further, the term “cannabis-induced psychosis” places a major explanatory emphasis on the substance use, ignoring other potential contributing factors such as vulnerability including genetic disposition for psychosis.Disclosure of InterestNone Declared